PRESS RELEASE published on 08/04/2026 at 10:11, 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of July 31, 2026. Regulatory announcement Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Capital Declaration
PRESS RELEASE published on 08/04/2026 at 10:11, 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Sartorius Stedim Biotech S.A. declares the number of shares and voting rights. Regulatory information in compliance with French law and AMF regulations Voting Rights Déclaration Shares Sartorius Stedim Biotech Regulatory Information
PRESS RELEASE published on 07/23/2026 at 10:10, 3 months 12 days ago Rapport financier semestriel de janvier à juin 2026
PRESS RELEASE published on 07/23/2026 at 09:22, 3 months 12 days ago First-Half Financial Report January to June 2026
BRIEF published on 07/23/2026 at 07:05, 3 months 12 days ago Performance semestrielle de Sartorius Stedim Biotech en 2026 Chiffre D'affaires EBITDA Sartorius Stedim Biotech Croissance Semestrielle Droits De Douane
BRIEF published on 07/23/2026 at 07:05, 3 months 12 days ago Sartorius Stedim Biotech Shows Steady Growth Amid Tariff Adjustments EBITDA Margin Sales Revenue Product Launches Biotech Growth Tariff Impact
BRIEF published on 07/23/2026 at 07:05, 3 months 12 days ago Sartorius Stedim Biotech affiche une croissance soutenue malgré les ajustements tarifaires Chiffre D'affaires Marge D'EBITDA Lancements De Produits Croissance Des Biotechnologies Impact Tarifaire
BRIEF published on 07/23/2026 at 07:05, 3 months 12 days ago Sartorius Stedim Biotech's half-year performance in 2026 EBITDA Revenue Sartorius Stedim Biotech Half-year Growth Customs Duties
PRESS RELEASE published on 07/23/2026 at 07:00, 3 months 13 days ago Sartorius Stedim Biotech continues positive development and expands profitable growth Sartorius Stedim Biotech reports robust growth in sales revenue, EBITDA, and net profit in H1 2026. The company confirms guidance for 2026 amid positive business development EBITDA Sartorius Stedim Biotech Sales Revenue Guidance H1 2026
PRESS RELEASE published on 07/23/2026 at 07:00, 3 months 13 days ago Sartorius Stedim Biotech poursuit son évolution positive et étend sa croissance rentable Sartorius Stedim Biotech annonce une croissance rentable au premier semestre 2026 malgré des effets non opérationnels, confirmant ses perspectives pour l'année Sartorius Stedim Biotech Croissance Rentable Résultat Semestriel Perspectives 2026 Évolution Positive
Published on 11/04/2026 at 23:10, 7 hours 52 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 8 hours 2 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 8 hours 47 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 8 hours 57 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 06:58, 3 minutes ago Aareal Bank leverages its operational strength to set the course for its strategic future
Published on 11/05/2026 at 06:58, 4 minutes ago AT&S reports record second-quarter results and fully confirms full-year guidance
Published on 11/05/2026 at 06:30, 32 minutes ago HENSOLDT increases adjusted EBITDA by 33% and refines guidance for 2026 upwards
Published on 11/05/2026 at 06:30, 32 minutes ago Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences
Published on 11/05/2026 at 06:20, 41 minutes ago Zhejiang Showcases Its Cultural and Tourism Appeal in Hamburg at "Come for the Stories" Event
Published on 11/04/2026 at 18:00, 13 hours 1 minute ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 13 hours 1 minute ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 13 hours 18 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
